Predictive risk score of respiratory complications in children with mediastinal tumors: A case–control study
Abstract Background The aim of this study was to examine risk factors of respiratory complications at the diagnosis and establish an algorithm of clinical management in children and adolescents with mediastinal tumors. Methods We retrospectively collected clinical information of all children and adolescents who presented with mediastinal tumors at Saitama Children's Medical Center from 1999 to 2019, including age, sex, pathological diagnosis, eight major clinical symptoms (cough, dyspnea, hypoxia, orthopnea, chest pain, wheeze, superior vena cava syndrome, and stridor), chest computed tomography (CT) findings (tumor location, mediastinal mass ratio, pleural fluid, pericardial effusion, and compression of trachea and bronchi), types of diagnostic procedure and anesthesia, respiratory complications (severe hypoxia, difficult ventilation, respiratory failure, and cardiopulmonary arrest), and clinical outcome. Subsequently, we calculated the risk score for predicting respiratory complications by combining clinical and radiological findings. Results Of the 57 patients, 7 (12%) developed respiratory complications. Cough, dyspnea, hypoxia, and orthopnea were significantly more common in patients with complications (p = 0.02, p = 0.02, p < 0.01, p = 0.03, respectively). The reduction of percentage of tracheal cross‐sectional area (%TCA) and compression of the carina in chest CT were also significantly more common in patients with complications (p < 0.01 and <0.01, respectively). We calculated the risk score of respiratory complications by combining cough, wheeze, stridor, orthopnea, dyspnea, hypoxia, %TCA < 0.5, and compression of the carina. A risk score ≥ 7 showed high predictive accuracy for complications (sensitivity: 100%, specificity: 97.7%, positive likelihood ratio: 43.0). Conclusion The risk score combining clinical symptoms with radiological findings is a promising predictive tool for respiratory complications in children with mediastinal tumors..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Cancer Medicine - 12(2023), 2, Seite 1167-1176 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mamoru Honda [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Children |
|---|
| doi: |
10.1002/cam4.4972 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ081436467 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ081436467 | ||
| 003 | DE-627 | ||
| 005 | 20230310214037.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230310s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/cam4.4972 |2 doi | |
| 035 | |a (DE-627)DOAJ081436467 | ||
| 035 | |a (DE-599)DOAJ8effd28481fe41a5a4b86d04e89ebdc3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC254-282 | |
| 100 | 0 | |a Mamoru Honda |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Predictive risk score of respiratory complications in children with mediastinal tumors: A case–control study |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Background The aim of this study was to examine risk factors of respiratory complications at the diagnosis and establish an algorithm of clinical management in children and adolescents with mediastinal tumors. Methods We retrospectively collected clinical information of all children and adolescents who presented with mediastinal tumors at Saitama Children's Medical Center from 1999 to 2019, including age, sex, pathological diagnosis, eight major clinical symptoms (cough, dyspnea, hypoxia, orthopnea, chest pain, wheeze, superior vena cava syndrome, and stridor), chest computed tomography (CT) findings (tumor location, mediastinal mass ratio, pleural fluid, pericardial effusion, and compression of trachea and bronchi), types of diagnostic procedure and anesthesia, respiratory complications (severe hypoxia, difficult ventilation, respiratory failure, and cardiopulmonary arrest), and clinical outcome. Subsequently, we calculated the risk score for predicting respiratory complications by combining clinical and radiological findings. Results Of the 57 patients, 7 (12%) developed respiratory complications. Cough, dyspnea, hypoxia, and orthopnea were significantly more common in patients with complications (p = 0.02, p = 0.02, p < 0.01, p = 0.03, respectively). The reduction of percentage of tracheal cross‐sectional area (%TCA) and compression of the carina in chest CT were also significantly more common in patients with complications (p < 0.01 and <0.01, respectively). We calculated the risk score of respiratory complications by combining cough, wheeze, stridor, orthopnea, dyspnea, hypoxia, %TCA < 0.5, and compression of the carina. A risk score ≥ 7 showed high predictive accuracy for complications (sensitivity: 100%, specificity: 97.7%, positive likelihood ratio: 43.0). Conclusion The risk score combining clinical symptoms with radiological findings is a promising predictive tool for respiratory complications in children with mediastinal tumors. | ||
| 650 | 4 | |a children | |
| 650 | 4 | |a mediastinal tumor | |
| 650 | 4 | |a respiratory complications | |
| 650 | 4 | |a risk score | |
| 650 | 4 | |a tracheal cross‐sectional area | |
| 653 | 0 | |a Neoplasms. Tumors. Oncology. Including cancer and carcinogens | |
| 700 | 0 | |a Arakawa Yuki |e verfasserin |4 aut | |
| 700 | 0 | |a Hosokawa Takahiro |e verfasserin |4 aut | |
| 700 | 0 | |a Oyama Chigusa |e verfasserin |4 aut | |
| 700 | 0 | |a Mitani Yuichi |e verfasserin |4 aut | |
| 700 | 0 | |a Mori Makiko |e verfasserin |4 aut | |
| 700 | 0 | |a Kohei Fukuoka |e verfasserin |4 aut | |
| 700 | 0 | |a Oshima Koichi |e verfasserin |4 aut | |
| 700 | 0 | |a Tanami Yutaka |e verfasserin |4 aut | |
| 700 | 0 | |a Ishimaru Tetsuya |e verfasserin |4 aut | |
| 700 | 0 | |a Kawashima Hiroshi |e verfasserin |4 aut | |
| 700 | 0 | |a Mizuta Koichi |e verfasserin |4 aut | |
| 700 | 0 | |a Ueta Ikuya |e verfasserin |4 aut | |
| 700 | 0 | |a Kuratani Norifumi |e verfasserin |4 aut | |
| 700 | 0 | |a Koh Katsuyoshi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Cancer Medicine |d Wiley, 2012 |g 12(2023), 2, Seite 1167-1176 |w (DE-627)DOAJ00006047X |x 20457634 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2023 |g number:2 |g pages:1167-1176 |
| 856 | 4 | 0 | |u https://doi.org/10.1002/cam4.4972 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/8effd28481fe41a5a4b86d04e89ebdc3 |z kostenfrei |
| 856 | 4 | 0 | |u https://doi.org/10.1002/cam4.4972 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2045-7634 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2023 |e 2 |h 1167-1176 | ||